{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:00:14Z","timestamp":1786993214413,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Photochemistry and Photobiology B: Biology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jphotobiol.2015.08.004","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T14:21:30Z","timestamp":1439389290000},"page":"233-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The phototoxicity of vemurafenib: An investigation of clinical monochromator phototesting and in vitro phototoxicity testing"],"prefix":"10.1016","volume":"151","author":[{"given":"J.A.","family":"Woods","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Degabriele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jphotobiol.2015.08.004_b0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/exd.12119","article-title":"Vemurafenib: an unusual UVA-induced photosensitivity","volume":"22","author":"Gelot","year":"2013","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.jphotobiol.2015.08.004_b0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1056\/NEJMc1113752","article-title":"Ultraviolet A and photosensitivity during vemurafenib therapy","volume":"366","author":"Dummer","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jphotobiol.2015.08.004_b0015","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/annonc\/mdt015","article-title":"Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients","volume":"24","author":"Boussemart","year":"2013","journal-title":"Ann. Oncol."},{"issue":"26","key":"10.1016\/j.jphotobiol.2015.08.004_b0020","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/phpp.12085","article-title":"Photosensitizing medications and photocarcinogenesis","volume":"30","author":"O\u2019Gorman","year":"2014","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0030","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/toxsci\/kft237","article-title":"Characterization of vemurafenib phototoxicity in a mouse model","volume":"137","author":"Boudon","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.jphotobiol.2015.08.004_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1751-1097.1997.tb08549.x","article-title":"5-aminolevulinic acid-based photodynamic therapy: principles and experimental research","volume":"65","author":"Peng","year":"1997","journal-title":"Photochem. Photobiol."},{"issue":"5","key":"10.1016\/j.jphotobiol.2015.08.004_b0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/lsm.20369","article-title":"Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre","volume":"38","author":"Moseley","year":"2006","journal-title":"Lasers Surg. Med."},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pdpdt.2009.12.001","article-title":"An overview of topical photodynamic therapy in dermatology","volume":"7","author":"Ibbotson","year":"2010","journal-title":"Photodiagnosis. Photodyn. Ther."},{"issue":"5","key":"10.1016\/j.jphotobiol.2015.08.004_b0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/apa.12554","article-title":"Effects of light on metalloporphyrin-treated newborn mice","volume":"103","author":"Wong","year":"2014","journal-title":"Acta. Paediatr."},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1203\/00006450-199301000-00018","article-title":"Role of lipid peroxidation in metalloporphyrin-mediated phototoxic reactions in neonatal rats","volume":"33","author":"Dennery","year":"1993","journal-title":"Pediatr. Res."},{"issue":"5","key":"10.1016\/j.jphotobiol.2015.08.004_b0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1751-1097.1983.tb04505.x","article-title":"The lipid solubility of porphyrins modulates their photo-toxicity in membrane models","volume":"37","author":"Emiliani","year":"1983","journal-title":"Photochem. Photobiol."},{"issue":"2\u20134","key":"10.1016\/j.jphotobiol.2015.08.004_b0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/1011-1344(90)85152-M","article-title":"Metalloporphyrin phototoxicity","volume":"7","author":"Scott","year":"1990","journal-title":"J. Photochem. Photobiol. B"},{"issue":"24","key":"10.1016\/j.jphotobiol.2015.08.004_b0070","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1073\/pnas.202607599","article-title":"The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria","volume":"99","author":"Jonker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1124\/jpet.112.192195","article-title":"Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) on the brain distribution of a novel BRAF inhibitor: vemurafenib (PLX4032)","volume":"342","author":"Mittapalli","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","article-title":"ABCG2: a perspective","volume":"61","author":"Robey","year":"2009","journal-title":"Adv. Drug. Deliv. Rev."},{"issue":"3","key":"10.1016\/j.jphotobiol.2015.08.004_b0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bcp.2012.11.003","article-title":"Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells","volume":"85","author":"Wu","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0781.2009.00487.x","article-title":"Which light source should be used for the investigation of clinical phototoxicity: monochromator or solar simulator?","volume":"26","author":"Moseley","year":"2010","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"6","key":"10.1016\/j.jphotobiol.2015.08.004_b0095","first-page":"932","article-title":"A micromethod for free erythrocyte porphyrins: the FEP test","volume":"81","author":"Piomelli","year":"1973","journal-title":"J. Lab. Clin. Med."},{"issue":"2","key":"10.1016\/j.jphotobiol.2015.08.004_b0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archderm.1974.01630080027007","article-title":"Rapid quantitative assay for erythrocyte porphyrins","volume":"110","author":"Poh-Fitzpatrick","year":"1974","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jphotobiol.2015.08.004_b0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jphotobiol.2013.07.003","article-title":"Differential sensitivity in cell lines to photodynamic therapy in combination with ABCG2 inhibition","volume":"126","author":"Barron","year":"2013","journal-title":"J. Photochem. Photobiol. B"},{"issue":"7","key":"10.1016\/j.jphotobiol.2015.08.004_b0110","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/jcp.54.7.500","article-title":"ACP Best Practice No 165: front line tests for the investigation of suspected porphyria","volume":"54","author":"Deacon","year":"2001","journal-title":"J. Clin. Pathol."},{"issue":"5","key":"10.1016\/j.jphotobiol.2015.08.004_b0115","first-page":"230","article-title":"Scottish UV dosimetry guidelines, \u201cScUViDo\u201d","volume":"17","author":"Moseley","year":"2001","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"2\u20133","key":"10.1016\/j.jphotobiol.2015.08.004_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.jphotobiol.2015.08.004_b0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.yrtph.2012.06.001","article-title":"The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing \u2013 the report of an ECVAM-EFPIA workshop","volume":"63","author":"Ceridono","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"3","key":"10.1016\/j.jphotobiol.2015.08.004_b0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0887-2333(00)00017-5","article-title":"Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity","volume":"14","author":"Traynor","year":"2000","journal-title":"Toxicol. In Vitro"},{"issue":"4","key":"10.1016\/j.jphotobiol.2015.08.004_b0135","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pdpdt.2013.08.004","article-title":"Porphyrin profile in four human cell lines after supplementation with 5-aminolaevulinic acid and its methyl ester","volume":"10","author":"Barron","year":"2013","journal-title":"Photodiagnosis. Photodyn. Ther."},{"issue":"1","key":"10.1016\/j.jphotobiol.2015.08.004_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(84)90192-X","article-title":"Urine and faecal porphyrin profiles by reversed-phase high-performance liquid chromatography in the porphyrias","volume":"139","author":"Lim","year":"1984","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.jphotobiol.2015.08.004_b0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0536.1993.tb03485.x","article-title":"Contact allergy to sunscreen chemicals in photosensitivity dermatitis\/actinic reticuloid syndrome (PD\/AR) and polymorphic light eruption (PLE)","volume":"29","author":"Bilsland","year":"1993","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.jphotobiol.2015.08.004_b0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0781.2009.00431.x","article-title":"Delayed ultraviolet erythema not suppressed by oral prednisolone: a randomized crossover study","volume":"25","author":"Muller","year":"2009","journal-title":"Photodermatol. Photoimmunol. Photomed."}],"container-title":["Journal of Photochemistry and Photobiology B: Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1011134415002444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1011134415002444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T16:51:01Z","timestamp":1760892661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1011134415002444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":30,"alternative-id":["S1011134415002444"],"URL":"https:\/\/doi.org\/10.1016\/j.jphotobiol.2015.08.004","relation":{},"ISSN":["1011-1344"],"issn-type":[{"value":"1011-1344","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phototoxicity of vemurafenib: An investigation of clinical monochromator phototesting and in vitro phototoxicity testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Photochemistry and Photobiology B: Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphotobiol.2015.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}